Tuesday

September 16

09.00 - 09.45

Keynote Speaker, Affiliation
Title (40 + 5 min)

9:45 - 10:15

Coffee Break

Session 1: Precision Diagnostics

Chair: Hege G. Russnes

10:15 - 10:45

Alona Sosinsky, Genomics England

Integrating whole genome sequencing into clinical practice for cancer patients (25 + 5 min)

10:45 - 11:00

Short Abstract Talk TBA

Title (10 + 5 min)

11:00 - 11:30

Janne Lehtiö, Karolinska Institutet

Title (25 + 5 min)

11:30 - 11:45

Short Abstract Talk TBA

Title (10 + 5 min)

11:45 - 12:15

Invited Speaker

Title (25 + 5 min)

12:15 - 13:00

Poster Session, Part 1

13:00 - 14:00

Lunch

14:00 - 15:00

Poster Session, Part 2

14:45 - 15:10

Coffee Break

Session 2: Precision immune oncology & Functional Precision Oncology

Chair: Kjetil Taskén

15:00 - 15:30

Diana Azzam, Florida International University

Title (25 + 5 min)

15:30 - 15:45

Short Abstract Talk TBA

Title (10 + 5 min)

15:45 - 16:15

Coffee Break

16:15 - 16:45

Thorsten Zenz, Univeristy Hospital Zurich

Title (25 + 5 min)

16:45 - 17:00

Short abstract talk TBA

Title (10 + 5 min)

17:00 - 17:30

Invited Speaker

Title (25 + 5 min)

19:15

Aperitif

20:00

Dinner

Wednesday

September 17

9:00 - 9:45

Keynote Speaker Patricia LoRusso
Yale Cancer Center
Title (40 + 5 min)

9:45 - 10:15

Coffee Break

Session 3A: Precision Cancer Medicine Trials

Chair: Åslaug Helland

10:15 - 10:45

Anna Martling, Karolinska Institutet

Title (25 + 5 min)

10:45 - 11:00

Short Abstract Talk TBA

Title (10 + 5 min)

11:00 - 11:30

Ruth Plummer, Newcastle University & Newcastle Hospitals NHS Foundation Trust, UK

Bench to Bedside for new Cancer Treatments– experience of academic drug discovery (25 + 5 min)

11:30 - 12:30

Lunch

Session 3B: PCM Trials

Chair: TBD

12:30 - 12:45

Short Abstract Talk TBA

Title (10 + 5 min)

12:45 - 13:15

Kimmo Porkka, Helsinki University Hospital

Functional tumor profiling and harmonized data networks for implementing precision cancer care (25 + 5 min)

Session 4: PCM Implementation

Chair: Live Fagereng

13:15 - 13:45

Christine Leopold, Utrecht Center for Pharmaceutical Policy and Regulation

Life cycle management of precision medicine: the case of managed entry agreements (25 + 5 min)

13:45 - 14:00

Short Abstract Talk TBA

Title (10 + 5 min)

14:00 - 14:25

Coffee Break

14:25 - 14:55

David Thomson, National Inst. for Health and Care Excellence (NICE), UK

Trends in pricing and reimbursement of PCM drugs (25 + 5 min)

14:55 - 15:10

Short Abstract Talk TBA

Title (10 + 5 min)

15:10 - 15:40

Invited Speaker

Title (25 + 5 min)

15:40 - 15:50

Concluding Remarks

Nordic Precision Cancer Medicine

An Acta Oncologica Conference

The overarching theme of this two-day conference is precision cancer medicine. Internationally renowned speakers will give scientific updates as well as updates on collaborative initiatives and implementation of precision cancer medicine across the Nordics and other European countries.

Program

Monday

Tuesday

Session 1: Precision Diagnostics

Session 2: Precision immune oncology & Functional Precision Oncology

Wednesday

Session 3A: Precision Cancer Medicine Trials

Session 3B: PCM Trials

Session 4: PCM Implementation

Nordic Precision Cancer Medicine

NPCM 2025

Pages: